July - September 2012

September 28, 2012		Pronova and Takeda Announce the New Drug Application Approval for Lotriga® 2g in Japan for the Treatment of Hyperlipidemia
September 26, 2012		Takeda has been selected for the third consecutive year for Dow Jones Sustainability Asia Pacific Index
September 12, 2012		Takeda Completes its Russian Pharmaceutical Manufacturing Facility
September 5, 2012		Revestive® (teduglutide) receives European marketing authorization for the treatment of adults with Short Bowel Syndrome (SBS)
August 31, 2012		Companies Submit Joint Application Seeking Approval for Additional Indication for Helicobacter pylori Eradication by Concomitant Therapy with Proton Pump Inhibitors, Amoxicillin Hydrate and either Clarithromycin or Metronidazole
August 29, 2012		Joint Research Agreement between the BC Cancer Agency and Takeda Pharmaceutical: Takeda to Initiate Joint Research at Shonan Incubation Laboratories
August 28, 2012		Notice Concerning the Determination of the Items of Stock Options (Stock Acquisition Rights) for Corporate Officers and Senior Management
August 27, 2012		Takeda Announces Appointment of New Senior Leadership
August 9, 2012		TAKEDA AND MILLENNIUM ANNOUNCE TERMINATION OF GANITUMAB PHASE 3 STUDY IN METASTATIC PANCREATIC CANCER IN JAPAN
August 3, 2012		Agreement on Exclusive Distributorship for Sales of Johnson & Johnson's Non-prescription Drugs in Japan
July 30, 2012		Notice Concerning Stock Options (Stock Acquisition Rights) for Corporate Officers and Senior Management
July 30, 2012		Takeda Announces Appointment of New Senior Leadership
July 28, 2012		Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
July 26, 2012		Takeda Initiates Phase 3 Trial of Motesanib in Japan and Additional Asian Countries
July 23, 2012		Takeda and Millennium Announce Positive CHMP Opinion for Conditional Approval of ADCETRIS® (brentuximab vedotin) in Europe
July 18, 2012		Notice Concerning the Determination of the Items of Stock Options (Stock Acquisition Rights) for Members of the Board of Directors
July 10, 2012		Takeda to price US$3 billion senior note offering
July 9, 2012		Takeda to announce U.S. dollar senior note offering
July 3, 2012		Takeda Completes Acquisition of Brazil's Multilab